NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » whitepapers » The growing importance of Israel and Türkiye in clinical trials

Oximio

White Paper

The growing importance of Israel and Türkiye in clinical trials

Patient pools in major global markets for clinical trials are at real risk of oversaturation, with sponsors and pharmaceutical companies finding it increasingly hard to identify and recruit participants with sufficient diversity and then retain them for the trial duration.

Download to find out more.

Download White Paper